Statement of the advisory commision of the section toxicology of the German society of experimental and clinical pharmacology and toxicology (DGPT) on possible health risks due to possible health risks due to di(2-ethylhexyl)phtalate (DEHP) from medical devices in neonatal intensive care units;Stellungnahme der beratungskommission der sektion toxikologie der Deutschen gesellschaft für experimentelle und klinische pharmakologie und toxikologie (DGPT) zu möglichen gesundheitsgefahren durch di(2-ethylhexyl)phthalat (DEHP) aus medizinprodukten in neonatologischen intensivstationen

Umweltmedizin in Forschung und Praxis

Volumn 8, Issue 1, 2003, Pages 25-30

  Kahl, Regine ^a   Degen, Gisela ^b   Foth, Heidi ^b   Kramer, Peter Jürgen ^b   Lilienblum, Werner ^b   Schrenk, Dieter ^b   Schulz, Thomas ^b   Schweinfurth, Hermann ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ADVISORY COMMITTEE; CLINICAL PHARMACOLOGY; DEVICE; EXPERIMENTAL TEST; GERMANY; HEALTH HAZARD; NEWBORN INTENSIVE CARE; NONHUMAN; SHORT SURVEY; SOCIETY; SYMPOSIUM; TOXICOLOGY;

EID: 0037236318     PISSN: 14308681     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (35)

1. AdvaMed (2001): AdvaMed Study No. 11974:21-day repeat dose male reproductive tract study of di(2-ethylhexyl)phthalate (DEHP) administered either intravenously or orally to rats starting at neonatal age 3-5 days, with satellite recovery group through 90 days of age.
2. Albro PW, Corbett JT, Schroeder JL, Jordan S, Matthews HB (1982): Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ Health Perspect 45, 19-25
3. Arcadi FA, Costa C, Imperatore C, Marchese A, Rapidisarda A, Salemi M, et al. (1998): Oral toxicity of bis(2-ethylhexyl)phthalate during pregnancy and suckling in Long-Evans rat. Food Chem Toxicol 36, 963-970
4. Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, et al. (1994): Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13, Suppl 2: S1-S117
5. Baxter (2000): Report No TP062830535: Histopathological evaluation of testes from neonatal male rats and rabbits treated with saline or approximately 62 mg/kg di(2-ethylhexyl)phthalate (DEHP) in 4% bovine serum albumin (BSA) during postnatal days 3-21 (rats) or 14-42 (rabbits), zitiert nach Center for Devices and Radiological Health (2001)
6. Bentley P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand H-J (1993): Hepatic peroxisome proliferation in rodents and its significance for humans. Chem Toxicol 31, 857-907
7. Center for Devices and Radiological Health U.S: Food and Drug Administration (2001): Safety Assessment of Di(2-ethylhexyl) phthalate (DEHP) Released from PVC Medical Devices
8. Dirven HAAM, van den Broek PHH, Peeters MCE, Peters JGP, Mennes WC, Blaauboer BJ, et al. (1993): Effects of the peroxisome proliferator mono (2-ethylhexyl) phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit and monkey. Biochem Pharmacol 45, 2425-2434
9. EU (2000): EU Final Draft (December 2000): Risk Assessment Bis(2-ethylhexyl)phthalate
10. Ganning AE, Brunk U, Edlund C, Elhammer A, Dallner G (1987): Effects of prolonged administration of phthalate esters on the liver. Environ Health Perspect 73, 251-258
11. Huber WW, Grasl-Kraupp B, Schulte-Hermann R (1996): Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol 26, 365-481
12. IARC, International Association for the Research on Cancer (1996): Clofibrate. Gemfibrozil. In: IARC monographs on the evaluation of carcinogenic risks to humans, Some pharmaceutical drugs. vol. 66. Lyon
13. Karle VA, Short BL, Martin GR, Bulas DI, Getson PR, Luban NLC, et al. (1997): Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate. Crit Care Med 25, 696-703
14. Kurata Y, Kidachi F, Yokoyama M, Toyota N, Tsuchitani M, Katoh M (1998): Subchronic toxicity of di-(2-ethylhexyl) phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol Sci 42, 49-56
15. Lamb JC (1987): IV. Reproductive effects of four phthalic acid esters in the mouse. Toxicol Appl Pharmacol 88, 255-269
16. Lee S-T, Pineau T, Drago J, et al. (1995): Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cellular Biol 15, 3012-3022
17. Li LH, Jester WF, Orth JM (1998): Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured Sertoli cells and gonocytes from neonatal rats. Toxicol Sci 153, 258-265
18. Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL (2000): Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. J Pediatr Surg 35, 1775-1781
19. Melnick RL (2001): Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di-(2-ethylhexyl)phthalate (DEHP)?. Environ Health Perspect 109, 437-442
20. Moore MR (1996): Oncogenicity study in rats with Di (-2ethylhexyl)phthalate including ancillary hepatocellular proliferation and biochemical analyses. Corning Hazleton Incorporated (CHV), 9200 Leesburg Pike, Vienna, Virginia 22182-1699.
21. Laboratory Study Identification: CHV 663-134; Sponsor: Eastman Chemical Company, First America Center, P.O. Box 1994 Kingsport, Tennessee 37662-5394, zitiert nach EU (2000).
22. National Toxicology Program, U.S: Department of Health and Human Services, Center for the Evaluation of Risks to Human Reproduction (2000): NTP-CERHR Expert Panel Report on Di(2-ethylhexyl)phthalate
23. Newman TB, Hulley SB (1996) Carcinogenicity of lipid-lowering drugs. JAMA 275, 55-60
24. Poon R, Lecavalier P, Mueller R, Valli VE, Procter BB, Chu I (1997): Subchronic oral toxicity of di-n-octyl phthalate and di(2-ethylhexyl)phthalate in the rat. Food Chem Toxicol 35, 225-239
25. Pugh G, Isenberg JD, Kamendulis KM, Ackley DC, Clare LJ, Brown R, et al. (2000): Effects of di-isononyl phthalate, di(2-ethylhexyl)-phthalate (DEHP) and clofibrate in cynomolgus monkeys. Toxicol Sci 56, 181-188
26. Rhodes C, Orton TC, Pratt IS, Batten PL, Bratt H, Jackson SJ, Elcombe CR (1986): Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl)phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man. Environ Health Perspect 65, 299-307
27. Schulte-Hermann R, Parzefall W (2001): A comprehensive literature review and toxicological risk assessment of possible effects on reproduction of di(2-ethylhexyl)phthalate (DEHP) and its metabolites from PVC-containing medical devices. Prepared for the Austrian Ministry for Social Security and Generations.
28. Schultz R, Yan W, Toppari J, Völkl A, Gustafsson J-A, Pelto-Huikko M (1999): Expression of peroxisome proliferator-activated receptor a messenger ribonucleic acid and protein in human and rat testis. Endocrinology 140, 2968-2975
29. Shneider B, Schena J, Truog R, Jacobson M, Kevy S (1989): Exposure to di(2-ethylhexyl)phthalate in infants receiving extracorporal membrane oxygenation. N Engl J Med 320, 1563
30. Sjöberg P, Bondesson U, Gray TJB, Plöen L (1986): Effects of di-(2-ethylhexyl)phthalate and five of its metabolites on rat testis in vivo and in vitro. Acta Pharmacol Toxicol 58, 225-233
31. Sjöberg P, Lindquist NG, Montin G, Plöen L (1985): Effects of repeated intravenous infusions of the plasticizer di-(2-ethylhexyl) phthalate in young male rats. Arch Toxicol 58, 78-83
32. Sjöberg PO, Bondesson UG, Sedin EG, Gustafsson JP (1985): Exposure of newborn infants to plasticizers. Plasma levels of di-(2-ethylhexyl)phthalate and mono-2-ethylhexyl)phthalate during exchange transfusion. Transfusion 25, 424-428
33. Tugwood JD, Aldridge TC, Lambe KG, McDonald N, Woodyatt NJ (1996): Peroxisome proliferator-activated receptors: structures and function. Ann N Y Acad Sci 804, 252-265
34. Ward JM, Peters JM, Perella CM, Gonzalez FJ (1998): Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol Pathol 26, 240-246
35. Woodyatt NJ, Lambe KG, Myers KA, Tugwood JD, Robert RA (1999): The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. Carcinogenesis 20, 369-372